Kevin T Whelan Selected Research

Obesity

1/2008	Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.
3/2005	Discovery and SAR of new benzazepines as potent and selective 5-HT(2C) receptor agonists for the treatment of obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin T Whelan Research Topics

Disease

2	Obesity 01/2008 - 03/2005
1	Weight Gain 01/2008
1	Cognitive Dysfunction 07/2003
1	Seizures (Absence Seizure) 07/2003

Drug/Important Bio-Agent (IBA)

2	5-HT2C Serotonin ReceptorIBA 01/2008 - 03/2005
1	Serotonin (5 Hydroxytryptamine)IBA 01/2008
1	lorcaserinIBA 01/2008
1	BenzazepinesIBA 03/2005
1	LigandsIBA 07/2003
1	4- ((2- (1- methyl- 2- pyrrolidinyl)ethyl)thio)phenol hydrochlorideIBA 07/2003